biosimilar

FDA
Marketing

Amneal, BioCorRx accused of ‘false and misleading’ promotions

Amneal and BioCorRx have earned the ire of the FDA’s Office of Prescription Drug Promotion.
Ben Adams Apr 10, 2026 8:41am
Eggs in an incubator

New egg-based drugmaker Neion Bio strikes biosimilar collab

Mar 26, 2026 1:00pm
drug prices biologics drug costs IRA money cash payment co-pay

Inside the turning tides of the US biosimilar market

Jan 8, 2026 9:00am
Sandoz

Sandoz's biosimilar to Biogen's Tysabri hits the US after delay

Nov 17, 2025 11:12am
red light stop light street traffic signal

Alvotech plant issues trigger another FDA biosimilar rejection

Nov 4, 2025 7:40am
partnership collaboration legal document

Regeneron, Celltrion shake hands on Eylea biosimilar settlement

Oct 22, 2025 8:15am